• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床应用 iPS 细胞治疗:希望与挑战。

Clinical therapy using iPSCs: hopes and challenges.

机构信息

State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.

出版信息

Genomics Proteomics Bioinformatics. 2013 Oct;11(5):294-8. doi: 10.1016/j.gpb.2013.09.002. Epub 2013 Sep 21.

DOI:10.1016/j.gpb.2013.09.002
PMID:24060840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4357821/
Abstract

Induced pluripotent stem cells (iPSCs) are generated by ectopic expression of defined transcription factors in somatic cells. They can undergo unlimited self-renewal and maintain the embryonic stem cells (ESCs)-like ability to differentiate into all three germ layers. iPSCs can potentially provide unlimited autologous cells for therapy and therefore hold great promise for regenerative medicine. Here we reviewed the recent advances in iPSC studies on disease modeling and clinical treatment as well as challenges correlated with clinical development of iPSCs, like tumorigenicity, immunogenicity and genomic instability.

摘要

诱导多能干细胞(iPSCs)是通过在体细胞中异位表达特定转录因子产生的。它们可以进行无限的自我更新,并保持胚胎干细胞(ESCs)样的能力,分化为所有三个胚层。iPSCs 有可能为治疗提供无限的自体细胞,因此为再生医学带来了巨大的希望。在这里,我们回顾了 iPSC 在疾病建模和临床治疗方面的最新进展,以及与 iPSC 临床开发相关的挑战,如致瘤性、免疫原性和基因组不稳定性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89f3/4357821/4e43a61935ef/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89f3/4357821/4e43a61935ef/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89f3/4357821/4e43a61935ef/fx1.jpg

相似文献

1
Clinical therapy using iPSCs: hopes and challenges.临床应用 iPS 细胞治疗:希望与挑战。
Genomics Proteomics Bioinformatics. 2013 Oct;11(5):294-8. doi: 10.1016/j.gpb.2013.09.002. Epub 2013 Sep 21.
2
The immunogenicity of cells derived from induced pluripotent stem cells.诱导多能干细胞衍生细胞的免疫原性。
Cell Mol Immunol. 2014 Jan;11(1):14-6. doi: 10.1038/cmi.2013.60. Epub 2013 Dec 16.
3
The genomic stability of induced pluripotent stem cells.诱导多能干细胞的基因组稳定性。
Protein Cell. 2012 Apr;3(4):271-7. doi: 10.1007/s13238-012-2922-8. Epub 2012 Apr 19.
4
Immunogenicity of induced pluripotent stem cells.诱导多能干细胞的免疫原性。
Nature. 2011 May 13;474(7350):212-5. doi: 10.1038/nature10135.
5
Cells derived from iPSC can be immunogenic - yes or no?iPSC 衍生细胞是否具有免疫原性?
Protein Cell. 2014 Jan;5(1):1-3. doi: 10.1007/s13238-013-0003-2.
6
Perspectives of induced pluripotent stem cells for cardiovascular system regeneration.诱导多能干细胞用于心血管系统再生的前景
Exp Biol Med (Maywood). 2015 May;240(5):549-56. doi: 10.1177/1535370214565976. Epub 2015 Jan 16.
7
Induced pluripotent stem cell (iPSCs) and their application in immunotherapy.诱导多能干细胞(iPSCs)及其在免疫疗法中的应用。
Cell Mol Immunol. 2014 Jan;11(1):17-24. doi: 10.1038/cmi.2013.62. Epub 2013 Dec 16.
8
Genomic Instability of iPSCs and Challenges in Their Clinical Applications.iPS 细胞的基因组不稳定性及其临床应用中的挑战。
Adv Exp Med Biol. 2019;1201:23-47. doi: 10.1007/978-3-030-31206-0_2.
9
Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications.iPS 细胞的基因组不稳定性:其临床应用面临的挑战。
Stem Cell Rev Rep. 2017 Feb;13(1):7-16. doi: 10.1007/s12015-016-9680-6.
10
Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.利用源自尿液细胞的患者特异性诱导多能干细胞对甲型血友病进行建模。
Life Sci. 2014 Jul 11;108(1):22-9. doi: 10.1016/j.lfs.2014.05.004. Epub 2014 May 13.

引用本文的文献

1
Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing.利用尿液来源的诱导多能干细胞推进细胞治疗、疾病建模和药物测试中的精准医学。
J Biomed Sci. 2024 May 9;31(1):47. doi: 10.1186/s12929-024-01035-4.
2
Harshening stem cell research and precision medicine: The states of human pluripotent cells stem cell repository diversity, and racial and sex differences in transcriptomes.强化干细胞研究与精准医学:人类多能干细胞库的多样性状况以及转录组中的种族和性别差异。
Front Cell Dev Biol. 2023 Jan 4;10:1071243. doi: 10.3389/fcell.2022.1071243. eCollection 2022.
3

本文引用的文献

1
Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells.用人类诱导多能干细胞衍生的心血管祖细胞重构成去细胞化的小鼠心脏。
Nat Commun. 2013;4:2307. doi: 10.1038/ncomms3307.
2
Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection.猪尾猕猴诱导多能干细胞来源的肝细胞支持丙型肝炎病毒感染。
Gastroenterology. 2013 Nov;145(5):966-969.e7. doi: 10.1053/j.gastro.2013.07.026. Epub 2013 Jul 25.
3
Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.
Non-coding RNAs: key regulators of reprogramming, pluripotency, and cardiac cell specification with therapeutic perspective for heart regeneration.
非编码 RNA:重编程、多能性和心脏细胞特化的关键调控因子,具有心脏再生的治疗前景。
Cardiovasc Res. 2022 Dec 9;118(15):3071-3084. doi: 10.1093/cvr/cvab335.
4
Rejuvenation of -Associated Atrophic Gastritis Through Concerted Actions of Placenta-Derived Mesenchymal Stem Cells Prevented Gastric Cancer.胎盘来源间充质干细胞协同作用使相关萎缩性胃炎年轻化预防了胃癌。
Front Pharmacol. 2021 Aug 18;12:675443. doi: 10.3389/fphar.2021.675443. eCollection 2021.
5
A Dedifferentiation Strategy to Enhance the Osteogenic Potential of Dental Derived Stem Cells.一种增强牙源性干细胞成骨潜能的去分化策略。
Front Cell Dev Biol. 2021 May 28;9:668558. doi: 10.3389/fcell.2021.668558. eCollection 2021.
6
PINK1-mediated mitophagy maintains pluripotency through optineurin.PINK1 介导的线粒体自噬通过 optineurin 维持多能性。
Cell Prolif. 2021 May;54(5):e13034. doi: 10.1111/cpr.13034.
7
Advances in Regeneration of Retinal Ganglion Cells and Optic Nerves.视网膜神经节细胞和视神经再生的研究进展。
Int J Mol Sci. 2021 Apr 28;22(9):4616. doi: 10.3390/ijms22094616.
8
Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis.涉及多能干细胞的临床试验的全球趋势:一项系统的多数据库分析。
NPJ Regen Med. 2020 Sep 11;5:15. doi: 10.1038/s41536-020-00100-4. eCollection 2020.
9
Corneal cell therapy: with iPSCs, it is no more a far-sight.角膜细胞治疗:有了 iPS 细胞,这不再是一个遥远的目标。
Stem Cell Res Ther. 2018 Oct 25;9(1):287. doi: 10.1186/s13287-018-1036-5.
10
Cardiovascular disease models: A game changing paradigm in drug discovery and screening.心血管疾病模型:药物发现和筛选的变革性范式。
Biomaterials. 2019 Apr;198:3-26. doi: 10.1016/j.biomaterials.2018.09.036. Epub 2018 Oct 1.
小分子化合物诱导的小鼠体细胞多能干细胞。
Science. 2013 Aug 9;341(6146):651-4. doi: 10.1126/science.1239278. Epub 2013 Jul 18.
4
Vascularized and functional human liver from an iPSC-derived organ bud transplant.源自 iPSC 衍生类器官芽移植的血管化和功能性人肝。
Nature. 2013 Jul 25;499(7459):481-4. doi: 10.1038/nature12271. Epub 2013 Jul 3.
5
The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis.多能性因子 Nanog 促进乳腺癌的发生和转移。
Oncogene. 2014 May 15;33(20):2655-64. doi: 10.1038/onc.2013.209. Epub 2013 Jun 17.
6
Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.使用患者特异性诱导多能干细胞研究致心律失常性右室心肌病。
Nature. 2013 Feb 7;494(7435):105-10. doi: 10.1038/nature11799. Epub 2013 Jan 27.
7
Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells.对来自同基因诱导多能干细胞的分化细胞缺乏免疫反应。
Cell Stem Cell. 2013 Apr 4;12(4):407-12. doi: 10.1016/j.stem.2013.01.006. Epub 2013 Jan 24.
8
Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.诱导多能干细胞或胚胎干细胞分化而来的终末细胞的免疫原性可忽略不计。
Nature. 2013 Feb 7;494(7435):100-4. doi: 10.1038/nature11807. Epub 2013 Jan 9.
9
Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome.多能性重编程因子与基因组初始结合的促进因素和阻碍因素。
Cell. 2012 Nov 21;151(5):994-1004. doi: 10.1016/j.cell.2012.09.045. Epub 2012 Nov 15.
10
Progressive degeneration of human neural stem cells caused by pathogenic LRRK2.致病性 LRRK2 导致人类神经干细胞进行性退化。
Nature. 2012 Nov 22;491(7425):603-7. doi: 10.1038/nature11557. Epub 2012 Oct 17.